Literature DB >> 16254355

Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.

Johannes Blümel1, Anna Maria Eis-Hübinger, Albert Stühler, Claudia Bönsch, Matthias Gessner, Johannes Löwer.   

Abstract

An infectious parvovirus B19 (B19V) genotype 2 variant was identified as a high-titer contaminant in a human plasma donation. Genome analysis revealed a 138-bp insertion within the p6 promoter. The inserted sequence was represented by an additional 30 bp from the end of the inverted terminal repeat adjacent to a 108-bp element found also, in inverted orientation, at the extreme right end of the unique sequence of the genome. However, despite the profound variations in the promoter region, the pattern of gene expression and DNA replication did not differ between genotype 1 and genotype 2 in permissive erythroid KU812Ep6 cells. Capsid proteins of both genotypes differ in their amino acid sequences. However, equivalent kinetics of virus inactivation at 56 degrees C or pH 4 indicated a comparable physicochemical stability of virus capsids. Sera from six individuals infected by B19V genotype 1 were investigated on cross-neutralization of B19V genotype 2 in vitro. Similar neutralization of both B19V genotypes was observed in sera from three individuals, while the sera from three other individuals showed weaker cross-neutralization for genotype 2. In conclusion, the in vitro replication characteristics and physical stability of B19V capsids are very similar between human parvovirus B19 genotypes 1 and 2, and cross-neutralization indicates a close antigenic relation of genotypes 1 and 2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254355      PMCID: PMC1280213          DOI: 10.1128/JVI.79.22.14197-14206.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.

Authors:  R O Shade; M C Blundell; S F Cotmore; P Tattersall; C R Astell
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  Identification and characterization of persistent human erythrovirus infection in blood donor samples.

Authors:  Daniel Candotti; Nermin Etiz; Armen Parsyan; Jean-Pierre Allain
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Construction and sequencing of an infectious clone of the human parvovirus B19.

Authors:  Ning Zhi; Zoltán Zádori; Kevin E Brown; Peter Tijssen
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

5.  A new parvovirus genotype persistent in human skin.

Authors:  Kati Hokynar; Maria Söderlund-Venermo; Maria Pesonen; Annamari Ranki; Olli Kiviluoto; Esa K Partio; Klaus Hedman
Journal:  Virology       Date:  2002-10-25       Impact factor: 3.616

6.  The structure of human parvovirus B19.

Authors:  Bärbel Kaufmann; Alan A Simpson; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

7.  Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2.

Authors:  Beate Schneider; Maria Becker; Hans-Hermann Brackmann; Anna Maria Eis-Hübinger
Journal:  Thromb Haemost       Date:  2004-10       Impact factor: 5.249

8.  Different susceptibility of B19 virus and mice minute virus to low pH treatment.

Authors:  Nicola Boschetti; Isabel Niederhauser; Christoph Kempf; Albert Stühler; Johannes Löwer; Johannes Blümel
Journal:  Transfusion       Date:  2004-07       Impact factor: 3.157

Review 9.  B19 virus genome diversity: epidemiological and clinical correlations.

Authors:  Giorgio Gallinella; Simona Venturoli; Elisabetta Manaresi; Monica Musiani; Marialuisa Zerbini
Journal:  J Clin Virol       Date:  2003-09       Impact factor: 3.168

10.  Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.

Authors:  Lutz Liefeldt; Annelie Plentz; Boris Klempa; Olivia Kershaw; Anne-Sophie Endres; Ulla Raab; Hans-H Neumayer; Helga Meisel; Susanne Modrow
Journal:  J Med Virol       Date:  2005-01       Impact factor: 2.327

View more
  12 in total

1.  Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

Authors:  Anna Ekman; Kati Hokynar; Laura Kakkola; Kalle Kantola; Lea Hedman; Heidi Bondén; Matthias Gessner; Claudia Aberham; Päivi Norja; Simo Miettinen; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

2.  Human B19 erythrovirus in vitro replication: what's new?

Authors:  Sylvie Pillet; Serge Fichelson; Frédéric Morinet; Neal S Young; Ning Zhi; Susan Wong
Journal:  J Virol       Date:  2008-09       Impact factor: 5.103

3.  Molecular characterization of human parvovirus B19 genotypes 2 and 3.

Authors:  Zhaojun Chen; Wuxiang Guan; Fang Cheng; Aaron Yun Chen; Jianming Qiu
Journal:  Virology       Date:  2009-09-15       Impact factor: 3.616

4.  Parvovirus B19 - Revised.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

5.  Human parvovirus B19: a mechanistic overview of infection and DNA replication.

Authors:  Yong Luo; Jianming Qiu
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

6.  Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.

Authors:  Mei-Ying W Yu; Harvey J Alter; Maria Luisa A Virata-Theimer; Yansheng Geng; Li Ma; Cathy A Schechterly; Camilla A Colvin; Naomi L C Luban
Journal:  Transfusion       Date:  2010-02-12       Impact factor: 3.157

Review 7.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

8.  Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue.

Authors:  Päivi Norja; Kati Hokynar; Leena-Maija Aaltonen; Renwei Chen; Annamari Ranki; Esa K Partio; Olli Kiviluoto; Irja Davidkin; Tomi Leivo; Anna Maria Eis-Hübinger; Beate Schneider; Hans-Peter Fischer; René Tolba; Olli Vapalahti; Antti Vaheri; Maria Söderlund-Venermo; Klaus Hedman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

9.  Genetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1.

Authors:  Craig Corcoran; Diana Hardie; Jane Yeats; Heidi Smuts
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

10.  Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Authors:  Heinz-Peter Schultheiss; Cornelia Piper; Olaf Sowade; Finn Waagstein; Joachim-Friedrich Kapp; Karl Wegscheider; Georg Groetzbach; Matthias Pauschinger; Felicitas Escher; Eloisa Arbustini; Harald Siedentop; Uwe Kuehl
Journal:  Clin Res Cardiol       Date:  2016-04-25       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.